Increased Platelet Sensitivity toward Platelet Inhibitors during Physical Exercise in Patients with Coronary Artery Disease

6533b82ffe1ef96bd12951e2

RESEARCH PRODUCT

Increased Platelet Sensitivity toward Platelet Inhibitors during Physical Exercise in Patients with Coronary Artery Disease

Bernd Klingel Stephan Lindemann Jürgen Meyer Andreas Fisch Harald Darius

subject

Blood Platelets medicine.medical_specialty Myocardial Ischemia Coronary Disease Prostacyclin Platelet Glycoprotein GPIIb-IIIa Complex Nitric Oxide Fibrinogen Thrombin Risk Factors Internal medicine medicine Humans Platelet cardiovascular diseases Platelet activation Endothelial dysfunction business.industry Thrombin Fibrinogen binding Hematology Middle Aged Platelet Activation medicine.disease Epoprostenol Radiography P-Selectin Endocrinology Exercise Test Cardiology business Platelet Aggregation Inhibitors medicine.drug Iloprost

description

Generalized atherosclerosis and coronary artery disease (CAD) are associated with endothelial dysfunction and during acute myocardial ischemia platelet activation has been reported. Activated platelets exert activated fibrinogen receptors (GP IIb/IIIa) and express CD 62p being regarded as reliable marker for platelet activation. Patients with angiographically proven CAD performed a bicycle exercise test until the onset of angina or ST-segment depression. We studied the ischemia-induced alterations in fibrinogen binding to activated platelet GP IIb/IIIa receptors and CD 62p expression. Therefore, the basal fibrinogen binding to GP IIb/IIIa and CD 62p expression and the thrombin-concentration for half-maximal platelet activation before and after exercise testing were determined. Additionally, inhibition of thrombin-induced platelet activation by increasing concentrations of the prostacyclin-analog iloprost and the NO-donor SIN-1 was examined. In patients with CAD, a significantly reduced basal activation and a highly significant reduction in sensitivity towards thrombin was measured. The thrombin-induced expression of GP IIb/IIIa and CD 62p was significantly diminished in patients with CAD after physical exercise and their platelets were significantly more sensitive towards the inhibitory effects of iloprost and SIN-1. These data demonstrate a significant reduction in platelet activation in response to physical exercise in patients with CAD and advanced atherosclerosis. Despite exercise induced myocardial ischemia as evidenced by angina and ECG-changes, the platelets are not generally activated, as it could be expected. Thus, patients with myocardial ischemia experienced a reduced platelet activity and enhanced sensitivity towards prostacyclin (PGI2) and nitric oxide, probably due to an augmented release of endogenous platelet inhibitory mediators.

year	journal	country	edition	language
1999-02-09	Thrombosis Research

https://doi.org/10.1016/s0049-3848(98)00155-8